Search

everythinglearnresearchcommunity

for

Search:↓

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

Belatacept may be a promising treatment for alopecia areata.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Blocking interferon-gamma might help treat various autoimmune diseases.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Biologics for severe asthma have known side effects, but some new risks need more study.

Biological therapy boosts the immune system to effectively fight melanoma.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

A woman with severe angioedema improved significantly after treatment with rituximab.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Upadacitinib improved multiple immune-related conditions in one patient.

Calancardin B may help reduce inflammation in immune cells.